Itamar Medical Ltd. – American – Consensus Indicates Potential 42.7% Upside

Broker Ratings

Itamar Medical Ltd. – American with ticker code (ITMR) now have 7 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 30 and 24.6 and has a mean target at 28.34. Now with the previous closing price of 19.86 this would indicate that there is a potential upside of 42.7%. The 50 day MA is 19.21 while the 200 day moving average is 21.14. The market capitalisation for the company is $261m. Company Website: http://www.itamar-medical.com

Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient’s peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index